NCT04490850

COVID-19 Seroprevalence Study in French Guiana

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 3,541 (actual)
• Sponsor: Institut Pasteur · Industry
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

Serological surveys measuring anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) antibodies in the population to assess the extent of the infection and the COVID-19 immunity of the population in French Guiana.

Detailed description

Serological surveys measuring anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) antibodies in the population to assess the extent of the infection and the COVID-19 immunity of the population in French Guiana. This study is a interventional study that present minimal risks and constraints. The results of the study will allow estimation of COVID-19 virus infection, severity and attack rates, as well as inform public health responses and policy decisions in the French Guiana territory.

Conditions

• Coronavirus Infection
• Severe Acute Respiratory Syndrome
• SARS-CoV Infection
• Covid19

Interventions

Type	Name	Description
PROCEDURE	Blood sample	Blood sample

Timeline

• Start date: 2020-07-15
• Primary completion: 2021-09-24
• Completion: 2021-09-24
• First posted: 2020-07-29
• Last updated: 2022-02-15

Locations

5 sites across 1 country: French Guiana